ZATA Pharmaceuticals, Inc.

ZATA is dedicated to the identification, characterization, development and commercialization of analogs of dinucleoside polyphosphates  as potential therapeutic agents; development of  technology of dual targeting of mRNA of microorganisms with novel synthetic modalities which exclusively target ribosome.  Synthesis of small genetic sequences designed to repair genetic diseases by specific insertion techniques.

ZATA is a startup pharmaceutical company based in Worcester, MA at   Massachusetts Biomedical Initiatives facilities.

.

ZATA’s pipeline comprises several streams of potential development by employing novel nucleic acid analogs plus small molecular combinations as potential therapeutic agents.